Welcome to our dedicated page for WaveDancer SEC filings (Ticker: WAVD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for WaveDancer, Inc. (WAVD) provides access to the company’s regulatory disclosures, including documents related to its merger with Firefly Neuroscience, Inc. and its transition toward operating as Firefly Neuroscience under a new ticker. Among the key filings referenced in company communications is the registration statement on Form S-4, which includes a proxy statement/prospectus describing the merger structure, the combination of WaveDancer and Firefly, and the anticipated name and ticker change for the combined company.
Through these filings, investors can review details about the Agreement and Plan of Merger, the formation of a WaveDancer merger subsidiary to combine with Firefly, and the plan for Firefly to become a wholly owned subsidiary of WaveDancer. The filings also describe the intention to sell WaveDancer’s current IT services business and to have the public company focus solely on Firefly’s medical technology and AI-enabled brain health platform.
Regulatory documents further outline corporate actions such as the reverse stock split of WaveDancer common stock at a one-for-three ratio and the planned change of the company’s name to Firefly Neuroscience, Inc., with common stock expected to trade on Nasdaq under the symbol AIFF following the split. These events are typically reported in current reports on Form 8-K and related exhibits, as well as in the proxy statement/prospectus included in the Form S-4.
On Stock Titan, SEC filings for WAVD are updated from EDGAR in near real time and paired with AI-powered summaries that explain the purpose and key points of each document. Users can quickly understand complex materials such as the Form S-4 registration statement, merger-related 8-Ks, and other periodic reports. The platform also surfaces information about governance changes and material agreements, helping investors follow how WaveDancer’s historical IT services company is being combined with Firefly Neuroscience and repositioned as an AI-driven brain health company.
Firefly Neuroscience, Inc. filed an 8-K describing two corporate actions. The company has terminated its equity line of credit arrangement with Arena Business Solutions Global SPC II, Ltd., which had allowed Arena to purchase up to $10 million of Firefly’s common stock. The company gave notice on September 4, 2025, with the termination effective as of September 11, 2025.
The Board also approved an amendment to the employment agreement for Chief Financial Officer Paul Krzywicki. Effective September 1, 2025, his annual gross base salary increases from CA$165,000 (approximately US$120,000) to CA$216,000 (approximately US$157,000), with all other terms of his agreement remaining unchanged.
Firefly Neuroscience, Inc. (WAVD) reported consolidated assets of $14,938 and cash of $5,918 at June 30, 2025, up from $4,601 and $1,810 at December 31, 2024. Revenue for the quarter was $299 and $342 for the six months, driven largely by the April 30, 2025 acquisition of Evoke Neuroscience, which contributed $251 of revenue and a $12 loss from April 30 to June 30. The company recorded a six-month net loss of $14,763 and an accumulated deficit of $106,257, resulting in basic and diluted loss per share of $1.69 for the six months. Shareholders' equity moved to $12,100 from a deficit of $(375) at year-end.
The acquisition cost totaled $6,221, producing $5,175 of goodwill and identifiable intangible assets including developed technology, trade name and non-compete agreements. Significant non-cash items materially affected results: a $9,369 change in derivative fair value and a $1,353 loss on settlement of a convertible promissory note. Operating cash used was $4,901 for six months while financing provided $11,388, primarily from equity issuances and warrant exercises. Management disclosed substantial doubt about the company’s ability to continue as a going concern but expects to seek additional capital.
WaveDancer, Inc. (CIK 0000803578) has filed a Form D on behalf of its subsidiary FIREFLY NEUROSCIENCE, INC. The filing notifies the SEC of a Rule 506(b) private placement of equity and related warrants/options. The total offering size is $2.0 million, of which $1.2 million (60%) has already been sold to two accredited investors since the first closing on 16-Jun-2025. $0.8 million remains available.
The offering is a new notice, is expected to last less than one year, and carries no minimum investment requirement. The issuer declined to disclose revenue or asset size and classifies itself under “Other Technology.” No sales commissions, finder’s fees, or payments to executive officers/directors are reported, suggesting the raise is being conducted directly by management in a cost-efficient manner.
Key executives named include CEO Greg Lipschitz, CFO Paul Krzywicki, and several board members. Proceeds are not earmarked for insider compensation, indicating funds are likely intended for operating or growth initiatives, although specific use is not disclosed in the form.
For investors, the filing signals (1) an additional capital infusion that may support product development in neuro-technology, (2) potential equity dilution depending on the terms of the securities issued, and (3) the company’s reliance on private accredited funding rather than public markets. Because the exemption used prohibits general solicitation, little further detail is available until subsequent disclosures or an S-1/8-K is filed.